Leading pharmaceutical firms fail to finalize business plan
Published: 2009-01-05 07:00:00
Updated: 2009-01-05 07:00:00
With a gloomy prospect that Korea's key industries are expected to suffer from a full-fledged global economic downturn this year as a result of the international financial market meltdown, major pharmaceutical companies may have to delay its business-related decisions.
Industry observers say t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
